Report : Middle East and Africa Coil Assisted Flow Diverters Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Wide-Neck Bifurcation Aneurysms and Narrow-Neck Bifurcation Aneurysms) and End User (Hospitals, Clinics, and Ambulatory Surgical Centers)
The wide-neck bifurcation aneurysms segment by application is estimated to lead the market growth during the forecast period.
According to a new market research study of “Middle East and Africa Coil Assisted Flow Diverters Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Application, End User and Country.” The Middle East and Africa coil assisted flow diverters market is expected to reach US$ 10.06 million by 2028 from US$ 7.12 million in 2021; it is estimated to grow at a CAGR of 5.1% from 2021 to 2028.The report highlights trends prevailing in the Middle East and Africa coil assisted flow diverters market and the factors driving market along with those that act as hindrances. Key factors that are driving growth of the market are rising incidence of intracranial aneurysms and growing incidence of hypertension, smoking, alcoholism, and obesity fuel the growth of the market. However, high cost of neurosurgical devices is expected to restrict the market growth during the forecast period.
Coil assisted flow diverters are stent-like devices that are used to for the embolization of intracranial aneurysms. Thus, increasing incidence of intracranial aneurysms is propelling the demand for coil assisted flow diverters. According to NCBI, in 2018, worldwide, almost 500,000 individuals will suffer from intracranial aneurysms each year, with almost two-thirds in low- and middle-income countries. Thus, increasing prevalence of intracranial aneurysms is creating high demand for coil assisted flow diverters. Also, hypertension, smoking, alcoholism, and obesity are associated with the development of brain aneurysms. Thus, increasing prevalence of these diseases is likely to fuel the demand for coil assisted flow diverters. In addition to this, the growing geriatric population, the rise in associated neurological disorders and technological advancements in coil assisted flow diverters across Middle Eastern countries are likely to create growth opportunities for the market.
Countries in the Middle East have also widely affected the socio-economic condition by the COVID–19 pandemic. The availability of vaccines and other healthcare facilities in the developing countries in the region is expected to provide scope for the market few years. The COVID-19 pandemic has helped the middle eastern countries like UAE and Saudi Arabia, to enhance their capacity and showcase their abilities for healthcare services. On the other hand, various developments have been done to test the presence of antibodies against COVID-19. In June 2020, two private hospitals in UAE named Mediclinic Middle East and King’s College Hospital London had initiated offering FDA-authorized COVID-19 serology test in public. The test confirms antibodies against COVID-19 that are produced by the immune system resulted from COVID-19. The availability of vaccines and other healthcare facilities in the developing countries in the Middle East region is expected to provide scope for the market few years.
The Middle East and Africa coil assisted flow diverters market, by application, is segmented into wide-neck bifurcation aneurysms, and narrow bifurcation aneurysms. Based on end user, the Middle East and Africa coil assisted flow diverters market is segmented into hospitals, clinics, and ambulatory surgical centers. Geographically, the Middle East and Africa coil assisted flow diverters market can be bifurcated into UAE, Saudi Arabia, South Africa and Rest of Middle East and Africa.
Balt USA LLC, Stryker Corporation, Penumbra, Inc, Medtronic, Acandis GmbH, MicroVention Inc, and Johnson and Johnson Services, Inc., are among the leading companies operating in the Middle East and Africa coil assisted flow diverters market.
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org